D-Finitive Cell Technologies Inc., located in Charleston, S.C., specializes in providing hematopoietic and other stem cell products, including cell culture media, and innovative growth factors. DCT provides contract research and development and custom products to Industrial partners and Distributors worldwide. Its team holds international acclaim in the cellular research arena with extensive competencies in growth formulations, bio-production, stem cell research, and manufacturing. The staff is headed by Paul Price, Ph.D. who is the Chief Scientific Officer. Dr. Price is the creator of many products currently used in the field of cellular research, including both stem and differentiated cells, and has played a key role in the development of formulations for the growth of cells used in the vaccine and bio-production industries.
Click here to read about the current state of our industry from D-Finitive's CSO, Dr. Paul Price.
